Whalesbook
Life Insurance Outlook
Emkay Global Financial Services projects a robust Q3 FY26 for India's insurance sector, anticipating healthy premium growth driven by favorable adjustments in the Goods and Services Tax (GST) regime. However, the brokerage cautions that profitability will likely remain constrained. Input tax credit (ITC) losses, increased commission payouts, and rising regulatory expenses are expected to weigh on insurer margins.
Life insurers are forecast to post strong growth in annualized premium equivalent (APE) for the December quarter. This surge is attributed to GST-led affordability improvements and a normalization of base effects following revised surrender value regulations. Protection products, particularly term insurance, are expected to be key volume drivers.
Private players such as Axis Max Life, SBI Life, HDFC Life, and ICICI Prudential Life are anticipated to lead this growth. State-owned Life Insurance Corporation of India (LIC) is also projected to report a substantial APE increase, benefiting from a strong retail client base and consistent group business traction.
Despite higher premiums, value of new business (VNB) margins are expected to face downward pressure. Emkay points to GST ITC losses as a primary factor, partially offset by a strategic shift towards higher-margin non-par and protection products. Increased gratuity provisions due to new labor codes are also anticipated to impact reported earnings.
General Insurance Momentum
The general insurance segment is poised for healthy gross written premium (GWP) expansion, primarily fueled by the motor and retail health insurance lines. Lower GST rates are expected to stimulate new vehicle sales, thereby boosting motor own-damage policy uptake.
Retail health insurance is also projected to witness strong demand, driven by enhanced affordability following GST exemptions. Group health insurance, however, may see more modest growth amidst intense market competition. Combined ratios are likely to remain elevated due to higher commission payouts, though some insurers might experience marginal improvements in their claims ratios.
Health Insurance Demand
The health insurance sector is anticipated to record robust growth in retail premiums. This optimism stems from GST exemptions and the normalization of base effects related to the 1/n regulation. Improved affordability is expected to significantly boost demand for individual health policies.
Claims ratios are expected to stay elevated, reflecting higher claim frequency and severity. Emkay continues to monitor medical cost inflation as a significant risk factor for the segment's profitability.
Market View
Looking ahead, Emkay forecasts life insurers to sustain healthy APE growth, with ongoing GST tailwinds and stabilizing base effects. General insurers are expected to maintain steady growth in motor and health segments. Health insurers should continue their premium expansion, benefiting from affordability gains and easing regulatory hurdles.
For equity investors, the report highlights that while regulatory overhangs, particularly concerning commissions, persist, a recovery in growth momentum and gradual improvements in profitability will be crucial determinants of insurance stock performance in the near term.